---
title: Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy
date: '2024-10-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39383458/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20241009193150&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Hematologic cancer developed in a subgroup of patients
  who were treated with eli-cel; the cases are associated with clonal vector insertions
  within oncogenes and clonal evolution with acquisition of somatic genetic defects.
  (Funded by Bluebird Bio; ALD-102, ALD-104, and LTF-304 ClinicalTrials.gov numbers,
  NCT01896102, NCT03852498, and NCT02698579, ...'
disable_comments: true
---
CONCLUSIONS: Hematologic cancer developed in a subgroup of patients who were treated with eli-cel; the cases are associated with clonal vector insertions within oncogenes and clonal evolution with acquisition of somatic genetic defects. (Funded by Bluebird Bio; ALD-102, ALD-104, and LTF-304 ClinicalTrials.gov numbers, NCT01896102, NCT03852498, and NCT02698579, ...